Low Glycemic Index diet effective in Drug Resistant Epilepsy in Children: Study
It is a well established fact that ketogenic dietary therapies(KD) are useful nonpharmacological therapeutic options in the management of drug resistant epilepsy but there are other dietary therapies such as modified Atkins diet(mAD), low glycemic index treatment(LGIT), and medium-chain triglyceride diet. LGIT diet includes food with a glycemic index less than 50 and is gaining popularity for treatment for epilepsy due to its effectiveness, mild side effect profile and more palatability.
Surbhi et al conducted a study to compare the efficacy of the modified Atkins diet (mAD) and low glycemic index treatment (LGIT) among children with drug-resistant epilepsy. The results were published in latest issue of Indian Pediatrics.
In this randomized controlled trial, children aged six months to 14 years with drug-resistant epilepsy (failure of adequate trials of two tolerated, appropriately chosen antiseizure drug schedules, whether as monotherapies or in combination to achieve sustained seizure freedom were enrolled after excluding children with inborn errors of metabolism and severe acute malnutrition. Eligible children were randomized into two groups –one with modified atkin's diet and other with low glycemic index therapy.A 24-hour dietary intake chart was reviewed at each visit to compute calorie and carbohydrate intake and to evaluate and reinforce compliance with the prescribed diet.All children were continued on anti-epileptic drugs accordingly.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.